财新传媒
财新英文 > 要闻 > 正文

In Depth: Common Steroid Shows Promise for Sickest Covid-19 Patients

2020年06月17日 20:18 来源于 财新网
Dexamethasone reduced deaths by one-third for patients on ventilators in Oxford University-backed study, though results have yet to be peer reviewed
In 1977, dexamethasone was added to the WHO’s Model List of Essential Medicines, a list of safe and effective drugs the organization considers vital to a basic health care system.

It may not be flashy or have big pharmaceutical backers, but an old, cheap and widely available steroid is showing it can keep some of the sickest coronavirus patients from dying, U.K. researchers say.

Medical experts who typically shy away from such language are hailing “breakthrough” results from a randomized controlled trial of the broad spectrum corticosteroid dexamethasone, which researchers said cut the risk of death for Covid-19 patients on ventilators by one-third.

版面编辑:喻竹杨洋
财新私房课
好课推荐
财新微信